Report Content
Chapter 1 Methodology & Scope
1.1 Market scope & definition
1.2 Base estimates & workings
1.3 Forecast calculations
1.4 Data Sources
1.4.1 Primary
1.4.2 Secondary
1.4.2.1 Paid sources
1.4.2.2 Unpaid sources
Chapter 2 Executive Summary
2.1 Global single-use bioreactors market 360° synopsis, 2018 – 2032
2.2 Regional trends
2.3 Product trends
2.4 Cell trends
2.5 Molecule trends
2.6 Usage trends
2.7 End-use trends
Chapter 3 Single-use Bioreactors Industry Insights
3.1 COVID- 19 impact analysis
3.2 Industry ecosystem analysis
3.3 Technology landscape
3.4 Regulatory landscape
3.5 Industry impact forces
3.5.1 Growth drivers
3.5.1.1 Growing pharmaceutical and biotechnology industry
3.5.1.2 Technological advancements in single-use bioreactors
3.5.1.3 Growing focus on orphan drug development
3.5.1.4 Rising demand for personalized medicines
3.5.2 Industry pitfalls & challenges
3.5.2.1 Low capacity of single-use bioreactors
3.5.2.2 Concerns regarding extractables and/or leachables
3.6 Growth potential analysis
3.6.1 By product
3.6.2 By cell
3.6.3 By molecule
3.6.4 By usage
3.6.5 By end-use
3.7 Porter's analysis
3.8 PESTEL analysis
Chapter 4 Competitive Landscape, 2022
4.1 Introduction
4.1.1 Thermo Fisher Scientific Inc.
4.1.2 Danaher Corporation
4.1.3 Merck KGaA
4.2 Competitive analysis of major market players, 2022
4.3 Competitive positioning matrix, 2022
4.4 Strategic outlook matrix, 2022
Chapter 5 Single-use Bioreactors Market Size and Forecast, By Product, 2018-2032 (USD Million)
5.1 Key trends, by product
5.2 Stirred tank single-use bioreactors
5.3 Wave-mixed single-use bioreactors
5.4 Bubble column single-use bioreactors
5.5 Other products
Chapter 6 Single-use Bioreactors Market Size and Forecast, By Cell , 2018-2032 (USD Million)
6.1 Key trends, by cell
6.2 Mammalian cells
6.3 Bacterial cells
6.4 Yeast cells
6.5 Other cells
Chapter 7 Single-use Bioreactors Market Size and Forecast, By Molecule, 2018-2032 (USD Million)
7.1 Key trends, by molecule
7.2 Monoclonal antibodies
7.3 Vaccines
7.4 Recombinant proteins
7.5 Stem cells
7.6 Gene therapy
7.7 Other molecules
Chapter 8 Single-use Bioreactors Market Size and Forecast, By Usage, 2018-2032 (USD Million)
8.1 Key trends, by usage
8.2 Developmental, pre-clinical & clinical
8.3 Commercial production
Chapter 9 Single-use Bioreactors Market Size and Forecast, By End-use, 2018-2032 (USD Million)
9.1 Key trends, by end-use
9.2 R&D organizations
9.3 Biopharma manufacturers
9.4 Contract manufacturing organizations
Chapter 10 Single-use Bioreactors Market Size and Forecast, By Region, 2018-2032 (USD Million)
10.1 Key trends, by region
10.2 North America
10.2.1 U.S.
10.2.2 Canada
10.3 Europe
10.3.1 Germany
10.3.2 UK
10.3.3 France
10.3.4 Italy
10.3.5 Spain
10.3.6 The Netherlands
10.3.7 Denmark
10.3.8 Rest of Europe
10.4 Asia Pacific
10.4.1 China
10.4.2 Japan
10.4.3 India
10.4.4 Australia
10.4.5 South Korea
10.4.6 Singapore
10.4.7 Rest of Asia Pacific
10.5 Latin America
10.5.1 Brazil
10.5.2 Mexico
10.5.3 Rest of Latin America
10.6 Middle East & Africa
10.6.1 South Africa
10.6.2 UAE
10.6.3 Rest of Middle East & Africa
Chapter 11 Company Profiles
11.1 Thermo Fisher Scientific
11.2 Solaris Biotech Solutions
11.3 Shanghai Bailun Biotechnology Co. Ltd.
11.4 Sartorius Stedim Biotech Group
11.5 Pierre Guerin Sas (Engie)
11.6 PBS Biotech
11.7 Danaher Corporation
11.8 Merck Group
11.9 GEA Group Aktiengesellschaft
11.10 Eppendorf AG
11.11 CESCO Bioengineering Co. Ltd.
11.12 CerCell ApS
11.13 Cellexus Ltd
11.14 Bbi Biotech
11.15 Applikon Biotechnology, Inc. (Getinge)
